Plasma levels of polyunsaturated fatty acids and multiple sclerosis susceptibility in a US case-control study
A higher total n-6 PUFA level may be beneficial in terms of MS susceptibility. Further research is needed to determine whether n-3 PUFAs may be beneficial only above a threshold that is achievable by supplementation.
Authors
- Eleanor Dunlop (ORCID: https://orcid.org/0000-0002-9139-015X)
- Gavin Pereira (ORCID: https://orcid.org/0000-0003-3740-8117)
- Lucinda J. Black (ORCID: https://orcid.org/0000-0003-4727-4773)
- Trevor Anthony Mori (ORCID: https://orcid.org/0000-0002-5264-9229)
- Alison Daly (ORCID: https://orcid.org/0000-0002-4919-5932)
- Annette Langer-Gould
Institutions
- Kaiser Permanente (US)
- Deakin University (AU)
- The University of Western Australia (AU)
- Curtin University (AU)
- Royal Perth Hospital (AU)
- Kaiser Permanente West Los Angeles Medical Center (US)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2024-10-06
- DOI
- https://doi.org/10.1016/j.msard.2024.105920
- Citations
- 6
- Primary Topic
- Fatty Acid Research and Health
- Type
- article
- Field-Weighted Citation Impact
- 1.86
Funders
- Multiple Sclerosis Australia
- Multiple Sclerosis Society of Western Australia
- National Institutes of Health
- National Health and Medical Research Council
- National Institute of Neurological Disorders and Stroke